Identificación y cuantificación del efecto fin de semana y festivos en la atención del síndrome coronario agudo en el Sistema Nacional de Salud / The effect of weekends and public holidays on the care of acute coronary syndrome in the Spanish National Health System

Introducción y objetivos Analizar si el ingreso en fin de semana o festivo (IFSF), frente al ingreso en días laborables, influye en el tratamiento (angioplastia, intervención coronaria percutánea [ICP]) y los resultados (mortalidad hospitalaria) de los pacientes hospitalizados por síndrome coronario agudo en el Sistema Nacional de Salud. Métodos Estudio observacional retrospectivo de pacientes ingresados por infarto agudo de miocardio con elevación del segmento ST (IAMCEST) o con síndrome coronario agudo sin elevación del segmento ST (SCASEST) en los hospitales del Sistema Nacional de Salud durante el periodo 2003-2018. Resultados Se seleccionaron 438.987 episodios de IAMCEST y 486.565 de SCASEST, de los cuales fueron IFSF el 28,8 y el 26,1% respectivamente. El IFSF se mostraba como un factor de riesgo de mortalidad hospitalaria en los modelos ajustados por riesgo del IAMCEST (OR=1,05; IC95%, 1,03-1,08; p<0,001) y del SCASEST (OR=1,08; IC95%, 1,05-1,12; p <0,001). La tasa de ICP en el IAMCEST fue más de 2 puntos porcentuales mayor en los pacientes ingresados en días laborables durante el periodo 2003-2011 y similar o incluso más baja en 2012-2018, sin cambios significativos para el SCASEST. El IFSF se mostró como factor de riesgo estadísticamente significativo tanto para el IAMCEST como para el SCASEST. Conclusiones El IFSF puede aumentar el riesgo de muerte hospitalaria en un 5% (IAMCEST) y un 8% (SCASEST). La persistencia del riesgo de mayor mortalidad hospitalaria tras ajustar por la realización de ICP y las demás variables explicativas probablemente indique dficiencias en el tratamiento durante el fin de semana respecto de los días laborables (AU)

Introduction and objectives To analyze whether admission on weekends or public holidays (WHA) influences the management (performance of angioplasty, percutaneous coronary intervention [PCI]) and outcomes (in-hospital mortality) of patients hospitalized for acute coronary syndrome in the Spanish National Health System compared with admission on weekdays. Methods Retrospective observational study of patients admitted for ST-segment elevation myocardial infarction (STEMI) or for non–ST-segment elevation acute coronary syndrome (NSTEACS) in hospitals of the Spanish National Health system from 2003 to 2018. Results A total of 438 987 episodes of STEMI and 486 565 of NSTEACS were selected, of which 28.8% and 26.1% were WHA, respectively. Risk-adjusted models showed that WHA was a risk factor for in-hospital mortality in STEMI (OR, 1.05; 95%CI,1.03-1.08; P < .001) and in NSTEACS (OR, 1.08; 95%CI, 1.05-1.12; P < .001). The rate of PCI performance in STEMI was more than 2 percentage points higher in patients admitted on weekdays from 2003 to 2011 and was similar or even lower from 2012 to 2018, with no significant changes in NSTEACS. WHA was a statistically significant risk factor for both STEMI and NSTEACS. Conclusions WHA can increase the risk of in-hospital death by 5% (STEMI) and 8% (NSTEACS). The persistence of the risk of higher in-hospital mortality, after adjustment for the performance of PCI and other explanatory variables, probably indicates deficiencies in management during the weekend compared with weekdays (AU)

Gasto sanitario público y mortalidad por COVID-19 en España y en Europa / Public healthcare expenditure and COVID-19 mortality in Spain and in Europe

Objetivo Analizar la asociación entre el gasto sanitario público per cápita y la tasa de mortalidad poblacional por COVID-19 en Europa y en España. Material y métodos Se utilizó el coeficiente de correlación de Pearson. Asimismo, se contrastaron los promedios de TMP-COVID-19 entre países y comunidades autónomas con mayor y menor GSPpc que el promedio. Resultados No se halló correlación, en los países europeos, entre el gasto sanitario público per cápita y la tasa de mortalidad poblacional por COVID-19 (r: 0,3; p = 0,14), ni en las comunidades autónomas (r: 0,03; p = 0,91). Tampoco se encontraron diferencias significativas en el contraste de la tasa de mortalidad poblacional por COVID-19 por grupos de gasto sanitario público per capita. Conclusiones La asociación entre «bajo» gasto sanitario público y malos resultados en España en la crisis de la COVID-19 no está sustentada en la evidencia disponible. Los aumentos de financiación de la sanidad pública deberían destinarse a las reformas estructurales para aumentar su eficiencia social (AU)

Objective To analyze the association between public health expenditure per capita and the mortality rate due to COVID-19 in Europe and Spain. Material and methods Pearson's correlation coefficient was used to compare and contrast the mortality rate due to COVID-19 between countries and autonomous communities with higher and lower public health expenditure per capita than the mean. Results No correlation between the public health expenditure per capita and the mortality rate due to COVID-19 (r: 0.3; p = 0.14) was found among European countries or Spain's Autonomous Communities (r: 0.03; p = 0.91). No significant differences were found when comparing the mortality rate due to COVID-19 among the public health expenditure per capita groups. Conclusions The available evidence does not support association between «low» public healthcare expenditure and the poor outcomes observed in Spain during the COVID-19 pandemic. Increased funding for the Spanish National Health System should be earmarked for structural reforms to increase its social efficiency (AU)

Public healthcare expenditure and COVID-19 mortality in Spain and in Europe.

OBJECTIVE: To analyze the association between public health expenditure per capita and the mortality rate due to COVID-19 in Europe and Spain. MATERIAL AND METHODS: Pearson's correlation coefficient was used to compare and contrast the mortality rate due to COVID-19 between countries and autonomous communities with higher and lower public health expenditure per capita than the mean. RESULTS: No correlation between the public health expenditure per capita and the mortality rate due to COVID-19 (r: 0.3; p = 0.14) was found among European countries or Spain's Autonomous Communities (r: 0.03; p = 0.91). No significant differences were found when comparing the mortality rate due to COVID-19 among the public health expenditure per capita groups. CONCLUSIONS: The available evidence does not support association between «low¼ public healthcare expenditure and the poor outcomes observed in Spain during the COVID-19 pandemic. Increased funding for the Spanish National Health System should be earmarked for structural reforms to increase its social efficiency.

[Public healthcare expenditure and COVID-19 mortality in Spain and in Europe]. / Gasto sanitario público y mortalidad por COVID-19 en España y en Europa.

OBJECTIVE: To analyze the association between public health expenditure per capita and the mortality rate due to COVID-19 in Europe and Spain. MATERIAL AND METHODS: Pearson's correlation coefficient was used to compare and contrast the mortality rate due to COVID-19 between countries and autonomous communities with higher and lower public health expenditure per capita than the mean. RESULTS: No correlation between the public health expenditure per capita and the mortality rate due to COVID-19 (r: 0.3; p = 0.14) was found among European countries or Spain's Autonomous Communities (r: 0.03; p = 0.91). No significant differences were found when comparing the mortality rate due to COVID-19 among the public health expenditure per capita groups. CONCLUSIONS: The available evidence does not support association between «low¼ public healthcare expenditure and the poor outcomes observed in Spain during the COVID-19 pandemic. Increased funding for the Spanish National Health System should be earmarked for structural reforms to increase its social efficiency.

An on-lattice agent-based Monte Carlo model simulating the growth kinetics of multicellular tumor spheroids.

PURPOSE: To develop an on-lattice agent-based model describing the growth of multicellular tumor spheroids using simple Monte Carlo tools. METHODS: Cells are situated on the vertices of a cubic grid. Different cell states (proliferative, hypoxic or dead) and cell evolution rules, driven by 10 parameters, and the effects of the culture medium are included. About twenty spheroids of MCF-7 human breast cancer were cultivated and the experimental data were used for tuning the model parameters. RESULTS: Simulated spheroids showed adequate sizes of the necrotic nuclei and of the hypoxic and proliferative cell phases as a function of the growth time, mimicking the overall characteristics of the experimental spheroids. The relation between the radii of the necrotic nucleus and the whole spheroid obtained in the simulations was similar to the experimental one and the number of cells, as a function of the spheroid volume, was well reproduced. The statistical variability of the Monte Carlo model described the whole volume range observed for the experimental spheroids. Assuming that the model parameters vary within Gaussian distributions it was obtained a sample of spheroids that reproduced much better the experimental findings. CONCLUSIONS: The model developed allows describing the growth of in vitro multicellular spheroids and the experimental variability can be well reproduced. Its flexibility permits to vary both the agents involved and the rules that govern the spheroid growth. More general situations, such as, e. g., tumor vascularization, radiotherapy effects on solid tumors, or the validity of the tumor growth mathematical models can be studied.

Results of R-ESHAP as salvage therapy in refractory/relapsed follicular lymphoma: a real-world experience on behalf of GELCAB group.

There is no standard treatment for relapsed follicular lymphoma (FL). Although platinum-based combinations are one of the most used treatments, few data have been reported in this setting. Our aim was to analyse R-ESHAP efficacy in relapsed FL patients. We retrospectively analysed 80 FL patients treated with R-ESHAP in the first or successive relapses. Responding patients received a stem cell transplantation following R-ESHAP. Seventeen histologically transformed patients were included. Median age was 50 years. At R-ESHAP initiation, 85% of the patients were in an advanced stage, 28% had a bulky disease and 40% had increased LDH. There were no statistically significant differences between POD24 and non-POD24 patients in terms of response to R-ESHAP (ORR 72% vs. 93%, p = 0.109). When analyzing R-ESHAP efficacy according to the response to the immediately previous line, patients achieving CR or PR had better CR rates to R-ESHAP than those who did not respond (CR of 57% vs. 15%, respectively, p = 0.009), as well as differences in OS (7.2 vs. 1.4 years, p < 0.0001) and in PFS (2.1 vs. 0.3 years, p < 0.0001). R-ESHAP is an effective treatment in relapsed FL patients who respond to the previous line and has to be considered as an adequate alternative for some patients.

Optimal control with MANF treatment of photoreceptor degeneration.

People afflicted with diseases such as retinitis pigmentosa and age-related macular degeneration experience a decline in vision due to photoreceptor degeneration, which is currently unstoppable and irreversible. Currently there is no cure for diseases linked to photoreceptor degeneration. Recent experimental work showed that mesencephalic astrocyte-derived neurotrophic factor (MANF) can reduce neuron death and, in particular, photoreceptor death by reducing the number of cells that undergo apoptosis. In this work, we build on an existing system of ordinary differential equations that represent photoreceptor interactions and incorporate MANF treatment for three experimental mouse models having undergone varying degrees of photoreceptor degeneration. Using MANF treatment levels as controls, we investigate optimal control results in the three mouse models. In addition, our numerical solutions match the experimentally observed surviving percentage of photoreceptors and our uncertainty and sensitivity analysis identifies significant parameters in the math model both with and without MANF treatment.

Evaluation of photosynthetic light integration by microalgae in a pilot-scale raceway reactor.

The improvement of photosynthetic efficiency in a 100 m2 raceway reactor by enhancement of light regime to which the cells are exposed is here reported. From Computational Fluid Dynamics it was calculated that the light exposure times ranged from 0.4 to 3.6 s while the exposure times to darkness were much longer, from 6 to 21 s. It was demonstrated that these times are too long for light integration, the cells fully adapting to local irradiances. This phenomenon was validated in the real outdoor raceway at different seasons. Simulations allows to confirm that if total light integration is achieved biomass productivity can increase up to 40 g/m2·day compared to 29 g/m2·day obtained considering local adaptation, which is close to the experimental value of 25 g/m2·day. This paper provides clear evidence of microalgae cell adaptation to local irradiance because of the unfavourable cell movement pattern in raceway reactors.

Loci Identification of a N-acyl Homoserine Lactone Type Quorum Sensing System and a New LysR-type Transcriptional Regulator Associated with Antimicrobial Activity and Swarming in Burkholderia Gladioli UAPS07070.

A random transposition mutant library of B. gladioli UAPS07070 was analyzed for searching mutants with impaired microbial antagonism. Three derivates showed diminished antimicrobial activity against a sensitive strain. The mutated loci showed high similarity to the quorum sensing genes of the AHL-synthase and its regulator. Another mutant was affected in a gene coding for a LysrR-type transcriptional regulator. The production of toxoflavin, the most well known antimicrobial-molecule and a major virulence factor of plant-pathogenic B. glumae and B. gladioli was explored. The absence of a yellowish pigment related to toxoflavin and the undetectable transcription of toxA in the mutants indicated the participation of the QS system and of the LysR-type transcriptional regulator in the regulation of toxoflavin. Additionally, those genes were found to be related to the swarming phenotype. Lettuce inoculated with the AHL synthase and the lysR mutants showed less severe symptoms. We present evidence of the participation of both, the quorum sensing and for the first time, of a LysR-type transcriptional regulator in antibiosis and swarming phenotype in a strain of B. gladioli.

Spoilage yeasts: What are the sources of contamination of foods and beverages?

Foods and beverages are nutrient-rich ecosystems in which most microorganisms are able to grow. Moreover, several factors, such as physicochemical characteristics, storage temperature, culinary practices, and application of technologies for storage, also define the microbial population of foods and beverages. The yeast population has been well-characterised in fresh and processed fruit and vegetables, dairy products, dry-cured meat products, and beverages, among others. Some species are agents of alteration in different foods and beverages. Since the most comprehensive studies of spoilage yeasts have been performed in the winemaking process, hence, these studies form the thread of the discussion in this review. The natural yeast populations in raw ingredients and environmental contamination in the manufacturing facilities are the main modes by which food contamination occurs. After contamination, yeasts play a significant role in food and beverage spoilage, particularly in the alteration of fermented foods. Several mechanisms contribute to spoilage by yeasts, such as the production of lytic enzymes (lipases, proteases, and cellulases) and gas, utilisation of organic acids, discolouration, and off-flavours. This review addresses the role of yeasts in foods and beverages degradation by considering the modes of contamination and colonisation by yeasts, the yeast population diversity, mechanisms involved, and the analytical techniques for their identification, primarily molecular methods.

A longitudinal communication approach in advanced lung cancer: A qualitative study of patients', relatives' and staff's perspectives.

Communication and the care of patients with advanced cancer are a dynamic, interactive and challenging process, often characterised in every day practice by discontinuity and lack of coordination. The objective of this study was to explore the patients' and family-caregivers' needs and preferences regarding communication, quality of life and care over the trajectory of disease. The second aim was to assess health professionals' views on a longitudinally structured, forward-thinking communication approach based on defined milestones. A qualitative approach was chosen incorporating semi-structured interviews with nine patients with metastatic lung cancer and nine relatives, and focus groups with 15 healthcare providers from different professions involved in the care of these patients. Patients and relatives described a situation of shock and coping deficits with moments of insufficient communication and lack of continuity in care. Healthcare providers reported the strong need for improvement in communication within the team and between patients and professionals and welcomed the implementation of a longitudinal communication approach. Requirements for the implementation of a longitudinal communication approach include specific communication training with focus on the process that patients and relatives are involved in. Team-building measures and the necessary flexibility to respect individuality in life should be incorporated.

Synergistic arsenic(v) and lead(ii) retention on synthetic jarosite. I. Simultaneous structural incorporation behaviour and mechanism.

Jarosite [KFe3(SO4)2(OH)6] minerals are effective scavengers of potentially toxic elements (PTEs) and are abundant, for example, in acid rock/mine drainage scenarios. The retention process is highly relevant for environmental attenuation of heavy metals and metalloids since these are usually highly soluble and thus mobile under acidic conditions. We investigated both macroscopically and at the molecular scale the extent and the effects of concomitant incorporation of As(v) and Pb(ii) into synthetic jarosite at different As/Pb starting molar ratios, using XRD-Rietveld, SEM, ATR-FTIR spectroscopy and wet chemistry. The amount of arsenate substituted in the jarosite structure was larger when Pb(ii) was also incorporated, the former filling up to approximately 33% of the tetrahedral sites normally occupied by SO42-, as compared to 21% when Pb(ii) was absent. Similarly, the amount of Pb(ii) incorporated in the structure was larger when As(v) was also taken up. The jarosite unit cell volume increased as higher amounts of As(v) incorporated into its structure, but simultaneous Pb(ii) incorporation seemed to limit this increase due to its smaller size as compared to K+. The extent to which As and Pb can accommodate in the jarosite structure was found to be limited by concentration maxima under the imposed synthesis conditions. At As/Pb ratios up to 1, Pb-As-jarosites were the only crystalline products. Above this ratio, a mixture of Pb-As-jarosite, anglesite (PbSO4) and poorly-crystalline ferric arsenate (AFA) phases was observed. At the highest As/Pb ratio investigated of 1.80 Pb-As-jarosite was no longer formed. Infrared spectroscopy analysis was applied for the first time here to substituted jarosites with both cations and anions, showing spectral changes in the solids as the As/Pb ratio increased: a characteristic As-O doublet at ∼810 and ∼855 cm-1 was observed upon Pb incorporation, showing an indirect effect of Pb(ii) on the As-O bonds in the jarosite structure. Thus, structural incorporation of Pb plays a pivotal role in the unit cell environment of jarosite to balance the distortion caused by AsO4-for-SO4 substitution. The retention processes found in this work have important environmental implications and impacts: through the synergistic incorporation encountered, remediation enhancement of cationic pollutants such as Pb(ii) is possible in a concomitant fashion with As(v) attenuation in acidic mining and metallurgical environments.

A comparative study in patients with fractures of the lower limbs between rivaroxaban versus enoxaparin and its impact on bone healing time.

BACKGROUND: Each year it is estimated in the United States an approximate of 8 million fractures; 5 to 10% develop delayed union or absence of periosteal new bone. There are several factors that can cause delay in fracture healing, among the well known, is the use of prophylactic antithrombotic therapy for deep vein thrombosis (DVT). DVT appears in 40 to 60% of the patients undergoing orthopedic surgery without prophylactic antithrombotic therapy. The goal of this study was to assess whether there is a difference in time of bone healing in lower limb fractures (femur and tibia) comparing rivaroxaban to enoxaparin as the prophylactic antithrombotic management. MATERIAL AND METHODS: We present a retrospective observational and analytic study in a sample of cases. It is a cross-sectional study with patient data from the database of the American British Cowdray (ABC) Medical Center. We included patients with femur and tibia fractures under antithrombotic prophylactic management with rivaroxaban or enoxaparin during the period of January 2011 to December 2012. Our sample included 32 patients separated into two groups. Students t-test was used for comparing parametric variables and the Mann-Whitney U test for nonparametric variables. Linear regression model was preformed considering the variables related to the time it took the fracture to heal. RESULTS: All fractures consolidated in a time of 13 and 14 weeks for rivaroxaban and enoxaparin respectively (p = 0.67). DISCUSSION: We found no difference in bone healing time for lower limb fractures in patients receiving antithrombotic prophylaxis treatment comparing rivaroxaban with enoxaparin.

ANTECEDENTES: En Estados Unidos se presentan aproximadamente ocho millones de fracturas anuales y de ellas entre cinco y 10% desarrollan retraso o ausencia en la consolidación ósea. Existen diferentes factores bien conocidos que promueven este retraso, entre los cuales se encuentra el uso de los antitrombóticos como terapia profiláctica de la trombosis venosa profunda, la cual aparece de 40 a 60% en pacientes que no los utilizan y son sometidos a cirugías ortopédicas. El objetivo de este estudio fue evaluar si existe diferencia en el tiempo de consolidación de las fracturas de los huesos de las extremidades pélvicas (fémur y tibia) en pacientes sometidos a terapia profiláctica antitrombótica comparando rivaroxabán con enoxaparina. MATERIAL Y MÉTODOS: Presentamos un estudio descriptivo y analítico con muestreo a conveniencia de casos retrospectivos. Es un estudio transversal con datos recolectivos. Se revisó la base de datos del Centro Médico ABC y se incluyeron pacientes con diagnóstico de fracturas de fémur y tibia sometidos a manejo profiláctico antitrombótico con rivaroxabán o enoxaparina durante el periodo de Enero 2011 a Diciembre de 2012. La muestra total se constituyó de 32 pacientes divididos en dos grupos. Se utilizó la prueba T de Student para comparar variables paramétricas y la prueba U de Mann-Whitney para las no-paramétricas. Se realizó un modelo de regresión lineal considerando las variables relacionadas con el tiempo de consolidación ósea. RESULTADOS: Todas las fracturas consolidaron, presentando un tiempo de 13 semanas con rivaroxabán y de 14 semanas (p = 0.67) con enoxaparina. DISCUSIÓN: No encontramos diferencia en el tiempo de consolidación de las fracturas de los huesos de las extremidades pélvicas (fémur y tibia) en pacientes que reciben antitrombóticos como profilaxis comparando rivaroxabán con enoxaparina.

Diplopía secundaria a osteoma frontoetmoidal gigante / Diplopia secondary to giant frontoethmoidal osteoma

No disponible

Análisis bibliométrico de los artículos originales publicados en la revista Ciencia & Trabajo: 1999-2015 / Bibliometric analysis of the original articles published in the journal Ciencia & Trabajo: 1999-2015

INTRODUCCIÓN: La Revista Ciencia y Trabajo (C&T) es editada por la Fundación Científica y Tecnológica de la Asociación Chilena de Seguridad desde 1999, publica trabajos científicos en temas relaciona dos con la seguridad e higiene industrial, salud ocupacional, calidad de vida laboral y otras disciplinas asociadas al trabajo y medio ambiente. OBJETIVO: Analizar la producción científica de los artículos originales publicados en C&T durante el periodo 1999-2015. MATERIAL Y MÉTODOS: Estudio bibliométrico descriptivo, longitudinal y retrospectivo. Se analizaron las características metodológicas y técnicas específicas en pre vención de riesgos laborales para cada uno de los artículos analizados, asimismo, la visibilidad en SciELO Analytics para los últimos años. RESULTADOS: Se publicaron un total de 430 artículos originales en 52 números con una media de 27 ± 8,8 artículos por año y 8 ± 2,6 artícu los por número. Los años con más artículos fueron 2009, 2010 y 2011. El número de autores por artículo oscila entre 1 a 4 (82%), en su mayo ría de universidades de Latinoamérica, destacando Chile, México y Brasil como los países de mayor contribución. La Psicosociología y Medicina del Trabajo son las temáticas más investigadas respecto a otras técnicas específicas en prevención de riesgos laborales como la Seguridad en el Trabajo y Ergonomía, predominando los estudios trans versales de carácter descriptivo-observacional en el idioma español. CONCLUSIONES: Se evidencia la consolidación de la revista a lo largo del tiempo. Por la antigüedad, publicación regular y demás atributos, la Revista C&T puede plantearse la posibilidad de ser indexada en la base de datos Scopus.

BACKGROUND: The journal Science and Work (C&T) has been pub lished by the Scientific and Technological Foundation of the Chilean Security Association since 1999, it publishes scientific papers on issues related to industrial safety and health, occupational health, quality of work life and other disciplines associated with Work and the environment. Objetive: To analyze the scientific production of the original articles published in C&T during the period 1999-2015. MATERIALS-METHODS: Descriptive, longitudinal and retrospective bibliometric study. We analyzed the specific methodological and technical characteristics in occupational risk prevention for each of the analyzed articles, as well as the visibility in SciELO Analytics for the last years. RESULTS: A total of 430 original articles were published in 52 numbers with an average of 27 ± 8.8 articles per year and 8 ± 2.6 articles per number, the years with the most articles were 2009, 2010 and 2011. The number of authors per article ranges from 1 to 4 (82%), mostly from Latin American universities, Chile, Mexico and Brazil being the countries with the highest contribution. Psychosociology and Occupational Medicine are the most researched topics in relation to other specific techniques in the prevention of occupational hazards such as Occupational Safety and Ergonomics, with cross - sectional descriptive - observational studies predominat ing in the spanish language. CONCLUSIONS: It is evident the consolida tion of the journal over time. Due to seniority, regular publication and other attributes, C&T can consider the possibility of being indexed in the Scopus database.

A comparative study in patients with fractures of the lower limbs between rivaroxaban versus enoxaparin and its impact on bone healing time / Estudio comparativo en pacientes con fracturas de extremidades inferiores entre rivaroxaban versus enoxaparina como terapia profiláctica antitrombótica y su impacto en el tiempo de consolidación

Abstract: Background: Each year it is estimated in the United States an approximate of 8 million fractures; 5 to 10% develop delayed union or absence of periosteal new bone. There are several factors that can cause delay in fracture healing, among the well known, is the use of prophylactic antithrombotic therapy for deep vein thrombosis (DVT). DVT appears in 40 to 60% of the patients undergoing orthopedic surgery without prophylactic antithrombotic therapy. The goal of this study was to assess whether there is a difference in time of bone healing in lower limb fractures (femur and tibia) comparing rivaroxaban to enoxaparin as the prophylactic antithrombotic management. Material and methods: We present a retrospective observational and analytic study in a sample of cases. It is a cross-sectional study with patient data from the database of the American British Cowdray (ABC) Medical Center. We included patients with femur and tibia fractures under antithrombotic prophylactic management with rivaroxaban or enoxaparin during the period of January 2011 to December 2012. Our sample included 32 patients separated into two groups. Student's t-test was used for comparing parametric variables and the Mann-Whitney U test for nonparametric variables. Linear regression model was preformed considering the variables related to the time it took the fracture to heal. Results: All fractures consolidated in a time of 13 and 14 weeks for rivaroxaban and enoxaparin respectively (p = 0.67). Discussion: We found no difference in bone healing time for lower limb fractures in patients receiving antithrombotic prophylaxis treatment comparing rivaroxaban with enoxaparin.

Resumen: Antecedentes: En Estados Unidos se presentan aproximadamente ocho millones de fracturas anuales y de ellas entre cinco y 10% desarrollan retraso o ausencia en la consolidación ósea. Existen diferentes factores bien conocidos que promueven este retraso, entre los cuales se encuentra el uso de los antitrombóticos como terapia profiláctica de la trombosis venosa profunda, la cual aparece de 40 a 60% en pacientes que no los utilizan y son sometidos a cirugías ortopédicas. El objetivo de este estudio fue evaluar si existe diferencia en el tiempo de consolidación de las fracturas de los huesos de las extremidades pélvicas (fémur y tibia) en pacientes sometidos a terapia profiláctica antitrombótica comparando rivaroxabán con enoxaparina. Material y métodos: Presentamos un estudio descriptivo y analítico con muestreo a conveniencia de casos retrospectivos. Es un estudio transversal con datos recolectivos. Se revisó la base de datos del Centro Médico ABC y se incluyeron pacientes con diagnóstico de fracturas de fémur y tibia sometidos a manejo profiláctico antitrombótico con rivaroxabán o enoxaparina durante el periodo de Enero 2011 a Diciembre de 2012. La muestra total se constituyó de 32 pacientes divididos en dos grupos. Se utilizó la prueba T de Student para comparar variables paramétricas y la prueba U de Mann-Whitney para las no-paramétricas. Se realizó un modelo de regresión lineal considerando las variables relacionadas con el tiempo de consolidación ósea. Resultados: Todas las fracturas consolidaron, presentando un tiempo de 13 semanas con rivaroxabán y de 14 semanas (p = 0.67) con enoxaparina. Discusión: No encontramos diferencia en el tiempo de consolidación de las fracturas de los huesos de las extremidades pélvicas (fémur y tibia) en pacientes que reciben antitrombóticos como profilaxis comparando rivaroxabán con enoxaparina.